Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
10.68
-0.04 (-0.37%)
Feb 21, 2025, 4:00 PM EST - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.62 billion as of February 21, 2025. Its market cap has decreased by -7.97% in one year.
Market Cap
7.62B
Enterprise Value
2.57B
1-Year Change
-7.97%
Ranking
Category
Stock Price
$10.68
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.62B, an increase of 1,328.77%. That is a compound annual growth rate of 88.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 7.62B | -11.51% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 791.96B |
| UnitedHealth Group | 423.17B |
| Johnson & Johnson | 386.71B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.41B |
| Abbott Laboratories | 233.37B |
| AstraZeneca | 227.07B |
| Merck & Co. | 222.56B |